Clinical Trials

Showing trials with last updates posted in 2026.

NCT06058377 | RECRUITING | PHASE3
3680 participants

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2023-11-27
Completion:
2032-05-31
Conditions
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Hormone Receptor-Positive Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT05945264 | NOT_YET_RECRUITING | NA
142 participants

Music Intervention for Preterm Birth

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2026-09-15
Completion:
2027-07-30
Conditions
  • Preterm Birth
Interventions
  • BEHAVIORAL
  • OTHER
No Results Yet
NCT05896839 | RECRUITING | PHASE1/PHASE2
16 participants

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2024-07-24
Completion:
2027-01-31
Conditions
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8
  • Metastatic Basal Cell Carcinoma
  • Metastatic Carcinoma in the Skin
  • Metastatic Melanoma
  • Metastatic Merkel Cell Carcinoma
  • Metastatic Skin Squamous Cell Carcinoma
  • Unresectable Basal Cell Carcinoma
  • Unresectable Melanoma
  • Unresectable Merkel Cell Carcinoma
  • Unresectable Skin Squamous Cell Carcinoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT05891171 | ACTIVE_NOT_RECRUITING | PHASE1
40 participants

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2023-10-13
Completion:
2027-09-30
Conditions
  • Advanced Cancer
  • Advanced Malignancies
  • Bladder Cancer
  • Cervical Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • Gastroesophageal-junction Cancer (GEJ)
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Non-Small Cell Lung Cancer (NSCLC)
  • Ovarian Cancer
  • Renal Cell Carcinoma (RCC)
  • Triple Negative Breast Cancer (TNBC)
Interventions
  • DRUG
No Results Yet
NCT05886036 | RECRUITING | PHASE2
70 participants

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2024-01-23
Completion:
2026-10-31
Conditions
  • Nodular Lymphocyte Predominant B-Cell Lymphoma
  • Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma
  • Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page